These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36041020)

  • 1. Delta-What? Deciphering the World of Cannabinoids.
    Volpe K; Wightman RS
    R I Med J (2013); 2022 Sep; 105(7):37-41. PubMed ID: 36041020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol.
    Abdel-Kader MS; Radwan MM; Metwaly AM; Eissa IH; Hazekamp A; ElSohly MA
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38542886
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis: pharmacology and toxicology in animals and humans.
    Adams IB; Martin BR
    Addiction; 1996 Nov; 91(11):1585-614. PubMed ID: 8972919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids: from pot to lab.
    Papaseit E; Pérez-Mañá C; Pérez-Acevedo AP; Hladun O; Torres-Moreno MC; Muga R; Torrens M; Farré M
    Int J Med Sci; 2018; 15(12):1286-1295. PubMed ID: 30275754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids.
    Heal DJ; Gosden J; Smith SL
    Front Psychiatry; 2024; 15():1322434. PubMed ID: 38915848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence.
    Chye Y; Kirkham R; Lorenzetti V; McTavish E; Solowij N; Yücel M
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):627-635. PubMed ID: 32948510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of cannabinoids in combination cancer therapy.
    Malhotra P; Casari I; Falasca M
    Adv Biol Regul; 2021 Jan; 79():100774. PubMed ID: 33422460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis, cannabinoids, and health.
    Lafaye G; Karila L; Blecha L; Benyamina A
    Dialogues Clin Neurosci; 2017 Sep; 19(3):309-316. PubMed ID: 29302228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The legalization of cannabinoid products and standardizing cannabis-drug development in the United States: a brief report
.
    Marcu J
    Dialogues Clin Neurosci; 2020 Sep; 22(3):289-293. PubMed ID: 33162772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis and Neuropsychiatric Disorders: An Updated Review.
    Chayasirisobhon S
    Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities.
    Lal S; Shekher A; Puneet ; Narula AS; Abrahamse H; Gupta SC
    Pharmacol Res; 2021 Jan; 163():105302. PubMed ID: 33246167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential.
    Tai S; Fantegrossi WE
    Curr Addict Rep; 2014 Jun; 1(2):129-136. PubMed ID: 26413452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids in clinical practice.
    Williamson EM; Evans FJ
    Drugs; 2000 Dec; 60(6):1303-14. PubMed ID: 11152013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Brief Background on Cannabis: From Plant to Medical Indications.
    Klumpers LE; Thacker DL
    J AOAC Int; 2019 Mar; 102(2):412-420. PubMed ID: 30139415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?
    Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL
    Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tetrahydrocannabinol pharmacokinetics; new synthetic cannabinoids; road safety and cannabis].
    Goullé JP; Guerbet M
    Bull Acad Natl Med; 2014 Mar; 198(3):541-56; discussion 556-7. PubMed ID: 26427296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis and cannabinoids: pharmacology and therapeutic potential.
    Śmiarowska M; Białecka M; Machoy-Mokrzyńska A
    Neurol Neurochir Pol; 2022; 56(1):4-13. PubMed ID: 35133644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis and synthetic cannabinoid exposure reported to the Israel poison information center: Examining differences in exposures to medical and recreational compounds.
    Sznitman SR; Pinsky-Talbi L; Salameh M; Moed T; Bentur Y
    Int J Drug Policy; 2020 Mar; 77():102711. PubMed ID: 32126489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids: for better and for worse
.
    Thibaut F; Hoehe MR
    Dialogues Clin Neurosci; 2020 Sep; 22(3):201-204. PubMed ID: 33162763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.